The purpose of the present study was to evaluate the newest status of patients diagnosed
Burkitt lymphoma (BL), an aggressive lymphoma subset with a high cure rate. Furthermore …

BACKGROUND Burkitt lymphoma (BL) is an aggressive but potentially curable lymphoma,
previously described in small, single‐institution studies. This study evaluated prognostic …

Burkitt lymphoma (BL) is a rare subtype of non-Hodgkin's lymphoma with an aggressive
course. To refine the individual patient's prognosis, the International Prognostic Index for BL …

Burkitt lymphoma (BL) is a rare neoplasm constituting 1–2% of adult lymphomas. Our aims
in this study were to establish prognostic factors for overall survival in adult BL and evaluate …

We examined adults with untreated Burkitt lymphoma (BL) from 2009 to 2018 across 30 US
cancer centers. Factors associated with progression-free survival (PFS) and overall survival …

PURPOSE Burkitt lymphoma (BL) has unique biology and clinical course but lacks a
standardized prognostic model. We developed and validated a novel prognostic index …

A recent population-based study on 2000 adult patients with Burkitt lymphoma presented a
novel score that takes into account age, race and clinical stage to prognosticate survival …

The treatment strategy for management of Burkitt lymphoma (BL) has evolved during the
past decades and the clinical outcome for this disease as a whole has also improved. Due to …

Abstract Introduction Adults with Burkitt lymphoma (BL) are at risk for both early toxic death
and disease progression. Age is associated with a poor prognosis with highly dose …

Abstract Background Adult sporadic Burkitt lymphoma (BL) is a rare but highly aggressive
subtype of lymphoma which lacks its own unique prognostic model. Systemic inflammatory …